HomepageMedicineAstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis Medicine AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis admin Posted on May 8, 2024 Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostMore ghost malls in the making as consumers shun poorly managed shopping centres Next PostHow Much Money Did This Year’s Met Gala Raise? You Might Also Like Medicine FDA Lifts Clinical Hold on Novavax’s Trials for COVID-19-Influenza Combination, Standalone Influenza Vaccines admin November 12, 2024 Medicine Sun Pharma, Philogen Ink Global Commercialization Deal for Fibromun, an Anti-Cancer Immunotherapy admin October 4, 2024 Medicine Trading Quality for Convenience? The New Tech Balancing Act admin October 12, 2024 Medicine FDA Accepts Biologics License Application for CSL Behring’s Garadacimab for Hereditary Angioedema admin December 24, 2023
Medicine FDA Lifts Clinical Hold on Novavax’s Trials for COVID-19-Influenza Combination, Standalone Influenza Vaccines admin November 12, 2024
Medicine Sun Pharma, Philogen Ink Global Commercialization Deal for Fibromun, an Anti-Cancer Immunotherapy admin October 4, 2024
Medicine FDA Accepts Biologics License Application for CSL Behring’s Garadacimab for Hereditary Angioedema admin December 24, 2023